Impact of anti-rheumatic drugs and steroids on clinical course and prognosis of COVID-19
- PMID: 32548723
- PMCID: PMC7297548
- DOI: 10.1007/s10067-020-05239-5
Impact of anti-rheumatic drugs and steroids on clinical course and prognosis of COVID-19
References
-
- Quartuccio L, Valent F, Pasut E, Tascini C, Vita S (2020, 2020) Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy. Joint Bone Spine S1297-319X(20)30088-9. 10.1016/j.jbspin.2020.05.00 - PMC - PubMed
-
- Moiseev S, Avdeev S, Brovko M et al (2020, 2020) Rheumatic diseases in intensive care unit patients with COVID-19. Ann Rheum Dis:annrheumdis-2020-217676. 10.1136/annrheumdis-2020-217676
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
